Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Aug 4, 2026 · Source: ClinicalTrials.gov
The study is underway but is not accepting new participants.
Observational
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Addario Lung Cancer Medical Institute
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
1. Men or women greater than or equal to 18 years of age at the time of consent 2. Ability to read, write and communicate in English 3. Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF) 4. Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required 5. Willing to comply with the requirements of the study 6. Diagnosis of extensive stage primary SCLC or tSCLC
1. Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements 2. Subjects who previously enrolled to this study Note: Concurrent enrollment in other clinical trials is NOT exclusionary
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Alabama
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Alaska
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Arizona
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Arkansas
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, California
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Colorado
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Connecticut
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Delaware
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, District of Columbia
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Florida
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Georgia
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.HtmlMultiple Locations, Hawaii
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 4, 2026. Always confirm current availability with the study team.